Core Insights - FiscalNote Holdings, Inc. reported a quarterly loss of $1.73 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.84, marking an earnings surprise of -105.95% [1] - The company's revenues for the quarter ended September 2025 were $22.43 million, missing the Zacks Consensus Estimate by 0.32%, and down from $29.44 million a year ago [2] - FiscalNote shares have declined approximately 74.2% year-to-date, contrasting with a 15.6% gain in the S&P 500 [3] Financial Performance - Over the last four quarters, FiscalNote has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.72 on revenues of $23.69 million, and for the current fiscal year, it is -$2.68 on revenues of $96.91 million [7] Market Outlook - The company's earnings outlook will be crucial for future stock performance, with management's commentary on the earnings call expected to influence investor sentiment [3][4] - The Zacks Industry Rank places Technology Services in the top 38% of over 250 industries, indicating a favorable environment for potential stock performance [8] Estimate Revisions - The trend for estimate revisions for FiscalNote was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market [6] - Empirical research indicates a strong correlation between near-term stock movements and earnings estimate revisions, which investors can track [5] Competitor Insights - Alithya Group, another company in the same industry, is expected to report quarterly earnings of $0.04 per share, with revenues projected at $89.59 million, reflecting a 9.6% increase from the previous year [9][10]

Core Viewpoint - Xponential Fitness reported quarterly earnings of $0.34 per share, significantly exceeding the Zacks Consensus Estimate of $0.14 per share, and showing a substantial improvement from a loss of $0.04 per share a year ago, indicating strong financial performance [1][2] Financial Performance - The company achieved revenues of $78.82 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.15%, although this represents a decline from year-ago revenues of $80.49 million [2] - Over the last four quarters, Xponential Fitness has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Xponential Fitness shares have declined approximately 51.3% since the beginning of the year, contrasting with the S&P 500's gain of 15.6%, indicating underperformance in the market [3] Future Outlook - The company's earnings outlook will be crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $0.20 on revenues of $78.7 million, and for the current fiscal year, it is $0.48 on revenues of $304.61 million [7] Industry Context - The Leisure and Recreation Services industry, to which Xponential Fitness belongs, is currently ranked in the top 28% of over 250 Zacks industries, suggesting a favorable industry outlook that could positively impact stock performance [8]

Core Insights - Eventbrite (EB) reported break-even quarterly earnings per share, exceeding the Zacks Consensus Estimate of a loss of $0.05, and showing an improvement from a loss of $0.04 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company posted revenues of $71.74 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.06%, but down from $77.8 million year-over-year [2] - Eventbrite shares have declined approximately 31.9% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The future performance of Eventbrite's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - Current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $75.21 million, and for the current fiscal year, it is -$0.15 on revenues of $293.51 million [7] Industry Context - The Internet - Services industry, to which Eventbrite belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Company Performance - Metallus (MTUS) reported quarterly earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.17 per share, and showing a significant improvement from a loss of $0.09 per share a year ago, resulting in an earnings surprise of +64.71% [1] - The company achieved revenues of $305.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.14% and increasing from $227.2 million year-over-year [2] - Over the last four quarters, Metallus has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Metallus shares have increased approximately 27.3% since the beginning of the year, outperforming the S&P 500's gain of 15.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.16 on revenues of $270.5 million, while for the current fiscal year, it is $0.59 on revenues of $1.14 billion [7] Industry Outlook - The Steel - Specialty industry, to which Metallus belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Metallus may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Insights - OptimizeRx Corp. reported quarterly earnings of $0.20 per share, significantly exceeding the Zacks Consensus Estimate of $0.03 per share, marking an earnings surprise of +566.67% [1] - The company achieved revenues of $26.07 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.25% and showing a year-over-year increase from $21.31 million [2] - OptimizeRx shares have increased approximately 294.2% year-to-date, outperforming the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $32.81 million, while the estimate for the current fiscal year is $0.67 on revenues of $107.38 million [7] - The estimate revisions trend for OptimizeRx was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Computer - Software industry, to which OptimizeRx belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Magic Software, is expected to report quarterly earnings of $0.29 per share, reflecting a year-over-year increase of +26.1% [9]

Core Insights - MidCap Financial Investment (MFIC) reported quarterly earnings of $0.38 per share, matching the Zacks Consensus Estimate, but down from $0.44 per share a year ago [1] - The company posted revenues of $82.58 million for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.79%, and showing a year-over-year increase from $82.14 million [2] - MidCap Financial shares have declined approximately 9.3% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Outlook - The future performance of MidCap Financial's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4] - The current consensus EPS estimate for the upcoming quarter is $0.38 on revenues of $82.51 million, and for the current fiscal year, it is $1.51 on revenues of $325.69 million [7] Industry Context - The Financial - Miscellaneous Services industry, to which MidCap Financial belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]

Core Viewpoint - QuinStreet reported quarterly earnings of $0.22 per share, matching the Zacks Consensus Estimate, and showing no change from the previous year [1] - The company achieved revenues of $285.85 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 2.10% and up from $279.22 million year-over-year [2] Financial Performance - Earnings per share (EPS) for the last quarter was $0.25, which was below the expected $0.26, resulting in a surprise of -3.85% [1] - Over the last four quarters, QuinStreet has not surpassed consensus EPS estimates [1] - The company has topped consensus revenue estimates three times in the last four quarters [2] Stock Performance - QuinStreet shares have declined approximately 35.4% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The current Zacks Rank for QuinStreet is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $271.91 million, and for the current fiscal year, it is $1.06 on revenues of $1.19 billion [7] - The outlook for the Internet - Delivery Services industry, where QuinStreet operates, is currently in the bottom 32% of over 250 Zacks industries, which may impact stock performance [8]

Core Insights - GoPro reported a quarterly loss of $0.09 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.03, marking an earnings surprise of -200.00% [1] - The company's revenues for the quarter ended September 2025 were $162.92 million, exceeding the Zacks Consensus Estimate by 0.51%, but down from $258.9 million year-over-year [2] - GoPro's stock has increased by approximately 62.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.6% [3] Financial Performance - Over the last four quarters, GoPro has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is $0.09 on revenues of $229.9 million, while for the current fiscal year, the estimate is -$0.14 on revenues of $678.94 million [7] Industry Context - GoPro operates within the Zacks Audio Video Production industry, which is currently ranked in the bottom 22% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of GoPro's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] Future Outlook - The sustainability of GoPro's stock price movement will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The estimate revisions trend for GoPro was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]

Core Viewpoint - Amphastar Pharmaceuticals reported quarterly earnings of $0.93 per share, exceeding the Zacks Consensus Estimate of $0.77 per share, but down from $0.96 per share a year ago, indicating a +20.78% earnings surprise [1][2] Financial Performance - The company achieved revenues of $191.84 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.96% and showing a slight increase from $191.21 million year-over-year [2] - Over the last four quarters, Amphastar has exceeded consensus EPS estimates three times and topped revenue estimates twice [2] Stock Performance - Amphastar shares have declined approximately 31.8% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The current Zacks Rank for Amphastar is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.96 on revenues of $195.8 million, and for the current fiscal year, it is $3.25 on revenues of $725.3 million [7] - The outlook for the Medical - Generic Drugs industry is favorable, ranking in the top 19% of over 250 Zacks industries, suggesting potential for outperformance [8]

Core Insights - Genpact reported quarterly earnings of $0.97 per share, exceeding the Zacks Consensus Estimate of $0.90 per share, and showing an increase from $0.85 per share a year ago, resulting in an earnings surprise of +7.78% [1] - The company achieved revenues of $1.29 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.10% and up from $1.21 billion year-over-year [2] - Genpact has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Genpact's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.93 on revenues of $1.28 billion, and for the current fiscal year, it is $3.55 on revenues of $5.01 billion [7] Industry Context - The Computers - IT Services industry, to which Genpact belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook for stocks within this sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]